EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
3,166
-146
-4% -$32K 0.6% 49
2026
Q1
$626K Hold
3,312
0.54% 57
2025
Q4
$563K Sell
3,312
-40
-1% -$6.13K 0.47% 64
2025
Q3
$442K Sell
3,352
-294
-8% -$35.3K 0.38% 81
2025
Q2
$387K Sell
3,646
-65
-2% -$7.06K 0.37% 88
2025
Q1
$461K Sell
3,711
-400
-10% -$52.2K 0.47% 74
2024
Q4
$506K Sell
4,111
-290
-7% -$34.2K 0.51% 61
2024
Q3
$490K Buy
4,401
+618
+16% +$67.7K 0.49% 70
2024
Q2
$404K Sell
3,783
-10
-0.3% -$1.1K 0.43% 75
2024
Q1
$457K Sell
3,793
-295
-7% -$36.1K 0.48% 68
2023
Q4
$503K Sell
4,088
-568
-12% -$70.9K 0.58% 57
2023
Q3
$603K Buy
4,656
+378
+9% +$50.4K 0.79% 37
2023
Q2
$530K Buy
4,278
+194
+5% +$26.1K 0.69% 47
2023
Q1
$598K Sell
4,084
-57
-1% -$8.43K 0.81% 41
2022
Q4
$660K Sell
4,141
-405
-9% -$59.4K 0.97% 35
2022
Q3
$606K Sell
4,546
-98
-2% -$14.9K 1.04% 32
2022
Q2
$725K Sell
4,644
-264
-5% -$40.6K 1.12% 30
2022
Q1
$764K Hold
4,908
0.99% 30
2021
Q4
$625K Buy
+4,908
New +$645K 0.82% 35

Other funds holding JAZZ

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's JAZZ Position: Q2 2026 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.4% in Q2 2026, selling an estimated $32K and leaving 3,166 shares worth $763K. The position accounts for 0.6% of the portfolio, ranked #49.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $764K in Q1 2022. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV held 3,166 shares of Jazz Pharmaceuticals worth $763K as of Q2 2026.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV sold 146 Jazz Pharmaceuticals shares in Q2 2026, an estimated $32K.
  • Jazz Pharmaceuticals made up 0.6% of EAGLE HARBOR ASSET MANAGEMENT INC /ADV's portfolio in Q2 2026, its #49 holding.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • EAGLE HARBOR ASSET MANAGEMENT INC /ADV's Jazz Pharmaceuticals position peaked at $764K in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q2 2026, filed 11 Aug 2026.